Champions Oncology: Soars after rise in oncology services boost qtrly rev
16/12/2019 22:13
** Cancer-focused R&D company's shares CSBR.O up 12.7% at
$8.58 after the closing bell; set for best day in almost three
months on Tuesday if gains hold
** Company reports 14% jump in Q2 rev, boosted by rise in
oncology services rev
** Reports Q2 adj. EPS of 3 cents, same as last year; Co
says will continue to be profitable for the year urn:newsml:reuters.com:*:nACSdDs4Ta
** Up to Monday's close, stock down ~3% YTD
(Reporting by Neha Malara in Bengaluru)
((Neha.Malara@thomsonreuters.com; within U.S.+1 646 223 8780;
outside U.S. +91 80 6749 0344;))